NIH-funded research Fellowship grant

How low oxygen levels affect immune cell behavior in pancreatic cancer

Official title: Hypoxic regulation of macrophage migration and function via fibroblast reprogramming in pancreatic cancer

Funded at University of Michigan at Ann Arbor · NIH-10929976 · Data updated 2026-11-12

This study is looking at how low oxygen levels in pancreatic cancer affect immune cells, especially those that help fight the cancer, to find out how they interact with other cells in the tumor and discover new ways to improve treatment.

More Pancreatic Cancer research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startAugust 1, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$42,094
NIH project number5F31CA281194-02
Project IDNIH-10929976 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are experiencing treatment resistance.

Less likely to help

Patients with other types of cancer or those not diagnosed with pancreatic cancer may not benefit from this research.

What this research studies

This research investigates how low oxygen levels in pancreatic cancer influence the behavior of immune cells, particularly macrophages. It focuses on understanding the interactions between these immune cells and cancer-associated fibroblasts in the tumor environment. By studying how hypoxia affects these cells, the research aims to uncover new mechanisms that contribute to cancer progression and resistance to treatment. The approach includes using animal models to observe changes in cell behavior in response to low oxygen conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance immune response against pancreatic cancer.

How similar studies have gone: Previous research has shown that targeting the tumor microenvironment can improve treatment outcomes in various cancers, suggesting potential success for this approach.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Hannifin, Sean Matthew — University of Michigan at Ann Arbor
  • Study coordinator: Hannifin, Sean Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.